Welcome to the A3BC.
One third of Australians suffer from arthritis, autoimmune or other musculoskeletal diseases, affecting adults, children and toddlers. These diseases cost Australia over $50 billion per year, account for the greatest disability, and further impact the community through substantial out-of-pocket expenses and reduced employment.
The primary scope of the A3BC research is to better understand genomic and environmental risk factors in Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA), Psoriatic Arthritis (PsA) and vasculitis. Other diseases such as Sjogren’s Syndrome, Lupus, Ankylosing Spondylitis, Scleroderma and Osteoarthritis are intended for future collection and research once the A3BC is established.
The A3BC hopes to find a cure for rheumatoid arthritis, juvenile arthritis and other MSK conditions, through cutting-edge, biobank-enabled research. Using a collaborative network of collection sites, biobanks and data linkage/modelling resources across leading sites in each Australian State/Territory, the A3BC will uncover hidden patterns and unknown correlations for preventive medicine, and generate new research questions to guide precision medicine towards safer and more effective therapy.
Please view our video below to better understand the A3BC vision: